Tag: PARTNER 2A
PCR London Valves 2019: PARTNER 2 analysis shows Sapien 3 valve as durable as surgical valves at four years
An analysis of structural valve deterioration in the PARTNER 2A trial has found that the third g...
TCT 2019: TAVI has sustained health status benefits over surgery for low-risk patients at one year, with similar five-year outcomes for intermediate-risk patients, unless via a transthoracic route
A subanalysis of PARTNER 3 quality of life data demonstrated a modest, but significant, improvem...
